Multiple Sclerosis: An Autoimmune Neurological Disease
Multiple sclerosis (MS) involves immune-mediated destruction of myelin sheaths surrounding nerve fibers. Environmental triggers, including chemical exposures, are hypothesized to initiate or accelerate MS progression.
PFAS Immune Effects Relevant to MS
PFAS alter T-cell differentiation, promoting pro-inflammatory Th17 responses implicated in MS pathogenesis. Studies show PFAS exposure correlates with elevated interleukin-17 levels and reduced regulatory T-cell function.
Myelin and PFAS Toxicity
Laboratory research demonstrates PFAS compounds disrupt oligodendrocyte precursor cell differentiation, impairing myelin repair. This mechanism could worsen demyelinating disease progression in genetically susceptible individuals.
Clinical Implications
MS patients with high PFAS serum levels show faster disability progression in some studies. Neurologists increasingly recommend PFAS exposure assessment as part of MS risk evaluation.